Soluble CD22 as a tumor marker for hairy cell leukemia

CD22 is an important immunotherapeutic target on B-cell malignancies, particularly hairy cell leukemia (HCL), but its soluble extracellular domain, sCD22, has not yet been reported in the blood. By immunoaffinity and enzyme-linked immunosorbent assay techniques using anti-CD22 monoclonal antibodies,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matsushita, Kakushi, Margulies, Inger, Onda, Masanori, Nagata, Satoshi, Stetler-Stevenson, Maryalice, Kreitman, Robert J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2008
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532804/
https://ncbi.nlm.nih.gov/pubmed/18596230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-131987
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares